Hancock Whitney’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.38M | Sell |
140,375
-4,912
| -3% | -$128K | 0.06% | 239 |
|
|
2026
Q1 | $3.91M | Sell |
145,287
-2,147
| -1% | -$57.2K | 0.07% | 221 |
|
|
2025
Q4 | $3.67M | Sell |
147,434
-38,635
| -21% | -$974K | 0.07% | 211 |
|
|
2025
Q3 | $4.74M | Sell |
186,069
-814,518
| -81% | -$20.1M | 0.09% | 177 |
|
|
2025
Q2 | $24.3M | Buy |
1,000,587
+848,274
| +557% | +$19.8M | 0.46% | 65 |
|
|
2025
Q1 | $3.86M | Buy |
152,313
+37,646
| +33% | +$985K | 0.13% | 122 |
|
|
2024
Q4 | $3.04M | Sell |
114,667
-25,251
| -18% | -$685K | 0.1% | 147 |
|
|
2024
Q3 | $4.05M | Sell |
139,918
-11,468
| -8% | -$335K | 0.13% | 118 |
|
|
2024
Q2 | $4.24M | Sell |
151,386
-191,500
| -56% | -$5.27M | 0.14% | 114 |
|
|
2024
Q1 | $9.52M | Buy |
342,886
+18,847
| +6% | +$523K | 0.33% | 72 |
|
|
2023
Q4 | $9.33M | Sell |
324,039
-43,025
| -12% | -$1.3M | 0.35% | 69 |
|
|
2023
Q3 | $12.2M | Sell |
367,064
-26,485
| -7% | -$937K | 0.5% | 51 |
|
|
2023
Q2 | $14.4M | Sell |
393,549
-170,388
| -30% | -$6.63M | 0.57% | 42 |
|
|
2023
Q1 | $23M | Sell |
563,937
-48,754
| -8% | -$2.11M | 0.92% | 18 |
|
|
2022
Q4 | $31.4M | Buy |
612,691
+154,338
| +34% | +$7.4M | 1.21% | 14 |
|
|
2022
Q3 | $20.1M | Sell |
458,353
-14,093
| -3% | -$685K | 0.86% | 24 |
|
|
2022
Q2 | $24.8M | Sell |
472,446
-2,575
| -0.5% | -$131K | 0.99% | 19 |
|
|
2022
Q1 | $24.6M | Sell |
475,021
-8,095
| -2% | -$420K | 0.84% | 28 |
|
|
2021
Q4 | $28.5M | Buy |
483,116
+1,135
| +0.2% | +$56.2K | 0.9% | 20 |
|
|
2021
Q3 | $20.7M | Sell |
481,981
-3,546
| -0.7% | -$157K | 0.72% | 32 |
|
|
2021
Q2 | $19M | Sell |
485,527
-63,898
| -12% | -$2.48M | 0.61% | 36 |
|
|
2021
Q1 | $19.9M | Sell |
549,425
-16,378
| -3% | -$582K | 0.68% | 27 |
|
|
2020
Q4 | $20.8M | Sell |
565,803
-26,573
| -4% | -$975K | 0.7% | 30 |
|
|
2020
Q3 | $20.6M | Sell |
592,376
-12,216
| -2% | -$428K | 0.76% | 25 |
|
|
2020
Q2 | $18.8M | Sell |
604,592
-112,591
| -16% | -$3.83M | 0.72% | 29 |
|
|
2020
Q1 | $22.2M | Buy |
717,183
+110,874
| +18% | +$3.78M | 0.87% | 21 |
|
|
2019
Q4 | $22.5M | Sell |
606,309
-36,393
| -6% | -$1.3M | 0.73% | 24 |
|
|
2019
Q3 | $21.9M | Buy |
642,702
+1,575
| +0.2% | +$57.3K | 0.72% | 21 |
|
|
2019
Q2 | $26.4M | Sell |
641,127
-35,365
| -5% | -$1.4M | 0.84% | 14 |
|
|
2019
Q1 | $27.3M | Sell |
676,492
-51,608
| -7% | -$2.07M | 0.87% | 11 |
|
|
2018
Q4 | $30.2M | Sell |
728,100
-29,976
| -4% | -$1.24M | 1.02% | 11 |
|
|
2018
Q3 | $31.7M | Buy |
758,076
+345,215
| +84% | +$13.3M | 0.9% | 9 |
|
|
2018
Q2 | $14.2M | Buy |
412,861
+328,142
| +387% | +$11.2M | 0.65% | 26 |
|
|
2018
Q1 | $2.85M | Sell |
84,719
-991
| -1% | -$34.1K | 0.13% | 172 |
|
|
2017
Q4 | $2.94M | Buy |
85,710
+4,047
| +5% | +$138K | 0.12% | 173 |
|
|
2017
Q3 | $2.77M | Sell |
81,663
-410
| -0.5% | -$13.2K | 0.12% | 170 |
|
|
2017
Q2 | $2.62M | Buy |
82,073
+52
| +0.1% | +$1.64K | 0.11% | 180 |
|
|
2017
Q1 | $2.66M | Buy |
82,021
+19,960
| +32% | +$629K | 0.11% | 185 |
|
|
2016
Q4 | $1.91M | Buy |
62,061
+751
| +1% | +$22.9K | 0.07% | 264 |
|
|
2016
Q3 | $1.97M | Buy |
61,310
+1,502
| +3% | +$50.2K | 0.08% | 254 |
|
|
2016
Q2 | $2M | Buy |
59,808
+27,499
| +85% | +$878K | 0.08% | 247 |
|
|
2016
Q1 | $908 | Sell |
32,309
-23,713
| -42% | -$677K | 0.04% | 321 |
|
|
2015
Q4 | $1.72M | Sell |
56,022
-2,950
| -5% | -$92.8K | 0.07% | 267 |
|
|
2015
Q3 | $1.76M | Buy |
58,972
+297
| +0.5% | +$9.52K | 0.07% | 257 |
|
|
2015
Q2 | $1.94M | Hold |
58,675
| – | – | 0.07% | 244 |
|
|
2015
Q1 | $1.94M | Buy |
58,675
+18,647
| +47% | +$593K | 0.07% | 244 |
|
|
2014
Q4 | $1.18M | Buy |
40,028
+1,063
| +3% | +$30.5K | 0.04% | 257 |
|
|
2014
Q3 | $1.09M | Sell |
38,965
-145,978
| -79% | -$4.1M | 0.04% | 266 |
|
|
2014
Q2 | $5.21M | Sell |
184,943
-66,451
| -26% | -$1.89M | 0.19% | 200 |
|
|
2014
Q1 | $7.66M | Buy |
251,394
+226,430
| +907% | +$6.75M | 0.3% | 133 |
|
|
2013
Q4 | $726K | Sell |
24,964
-1,054
| -4% | -$30.7K | 0.03% | 303 |
|
|
2013
Q3 | $709K | Sell |
26,018
-221,502
| -89% | -$6.03M | 0.03% | 295 |
|
|
2013
Q2 | $6.58M | Buy |
+247,520
| New | +$6.84M | 0.33% | 89 |
|
Other funds holding PFE
Hancock Whitney's PFE Position: Q2 2026 in Review
Hancock Whitney reduced its Pfizer (PFE) stake by 3.4% in Q2 2026, selling an estimated $128K and leaving 140,375 shares worth $3.38M. The position accounts for 0.06% of the portfolio, ranked #239.
Hancock Whitney first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.7M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hancock Whitney held 140,375 shares of Pfizer worth $3.38M as of Q2 2026.
- Hancock Whitney sold 4,912 Pfizer shares in Q2 2026, an estimated $128K.
- Pfizer made up 0.06% of Hancock Whitney's portfolio in Q2 2026, its #239 holding.
- Hancock Whitney first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Hancock Whitney's Pfizer position peaked at $31.7M in Q3 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.